IHL
Click for more information
0.00% 4.1¢ incannex healthcare limited

Ann: Independent data review commences for Ph 2 trial psilocybin, page-5

  1. Flectional
    4,408 Posts.
    lightbulb Created with Sketch. 8522
    clock Created with Sketch.
    18/01/23
    08:54
    Post #: 65744326
    'the trial continues to progress well and on time with retention of all participants who have been enrolled - the trial team have identified no safety concerns to date '

    very nice update

    IHL Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 28  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS The psychology of spending: How to manage finances wisely
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Major high-grade gold discovery at Claw Project – promising results revealed!
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.